2,5-Bis(2,2,2-trifluoroethoxy)benzoic acid, 95.0%, 25g

(S)-2-Methyl-N-[(2S)-1,1,1-trifluoro-4-oxo-4-phenylbutan-2-yl]propane-2-sulfinamide, 250mg

Oxalato de estroncio monohidrato, mínimo 95 %, puro, 500 g, envase de plástico.

2-Ethylhexyl Diphenyl Phosphate>90.0%(GC)500g

1-(Benzyloxy)-3-(bromomethyl)benzene, 95.0%, 100g

2-Chloro-4-iodo-6-(trifluoromethoxy)pyridine, 95.0%, 5g

Boc-4-acetyl-L-phenylalanine, 98.0%, 1g

3,7-Bis(methylthio)dibenzo[b,d]thiophene, 97.0%, 1g

2-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-1,2,3-triazole, 97%, 1g

(hydroxyimino)(4-(5-(trifluoromethyl)(2-pyridyloxy))phenyl)methylamine, 97%, 95.0%, 1g

1-Benzyl-1 H -pyrazol-3-ylamine, 95.0%, 25g

4-[(butylamino)methyl]-2-ethoxyphenol, 95.0%, 10g

tert-butyl 5-oxo-4,7-diazaspiro[2.5]octane-7-carboxylate, 95.0%, 100mg